The Magazine for Sleep Professionals
Monday, February 23, 2026
Resmed, announced the launch of the AirTouch™ F30i Comfort mask in the United States, a new CPAP (continuous positive airway pressure) full face mask. With a soft, breathable1 fabric, the AirTouch F30i Comfort is designed to help more people start and stay on CPAP therapy. The AirTouch F30i Comfort reflects Resmed’s dedication […]
Resmed announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to improving the way care is delivered by making it more accessible, coordinated, and patient-friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to […]
Resmed announced its home sleep apnea test, NightOwl™, is now available across the United States. NightOwl is an FDA-cleared home sleep apnea test (HSAT) designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea (OSA) from the comfort of an individual’s home. OSA, a […]
ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for healthcare providers to treat sleep apnea and to help patients start and […]
React Health has announced the appointment of Bill Shoop as its Chief Executive Officer. Bill brings two decades of invaluable experience in the healthcare industry, with his most recent role being Vice President and General Manager of ResMed North America. In his previous capacity at ResMed, Shoop demonstrated his exceptional […]
By RTSleepWorld Staff In an effort to furnish patients and healthcare professionals with the most current and comprehensive guidance concerning the secure utilization of ResMed masks equipped with magnets, ResMed has issued an Urgent Field Safety Notice and has revised the contraindications and warnings sections within its user guides. This […]
Nyxoah SA today announced that the Company has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. […]
ResMed today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment […]
Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed and presented at the American Thoracic Society’s annual International Conference. The retrospective, observational study analyzed the deidentified usage data of 180,000 U.S. […]
ResMed announced the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results […]
